Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: Correlation with MRI findings

American Journal of Roentgenology

Volumn 199, Issue 2, 2012, Pages 341-348

  Laumonier, Hervé ^a   Cailliez, Hélène ^a   Balabaud, Charles ^a,b   Possenti, Laurent ^a   Zucman Rossi, Jessica ^c,d   Bioulac Sage, Paulette ^b,e   Trillaud, Hervé ^a,f  

^a HÔPITAL SAINT ANDRÉ   (France)

^b INSERM   (France)

^c Université Paris 13   (France)

^d UNIVERSITÉ PARIS DIDEROT   (France)

^e HÔPITAL PELLEGRIN   (France)

^f CNRS   (France)

Author keywords

Contrast enhanced ultrasound; Hepatocellular adenoma; Phenotype classification

Indexed keywords

GADOTERATE MEGLUMINE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; SONOVUE;

ADULT; AGED; ARTICLE; B SCAN; BETA CATENIN ACTIVATED HEPATOCELLULAR ADENOMA; CLINICAL ARTICLE; CONTRAST ENHANCED SONOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; FEMALE; GRAY SCALE ECHOGRAPHY; HEPATOCELLULAR ADENOMA; HEPATOCYTE NUCLEAR FACTOR 1A INACTIVATED HEPATOCELLULAR ADENOMA; HUMAN; HUMAN TISSUE; INFLAMMATORY HEPATOCELLULAR ADENOMA; LIVER ADENOMA; MALE; MICROBUBBLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADENOMA, LIVER CELL; ADULT; BETA CATENIN; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; INFLAMMATION; LIVER NEOPLASMS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PHENOTYPE; PHOSPHOLIPIDS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 84864745392     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7046     Document Type: Article

References (19)

1. Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009; 50:481-489
2. Bluteau O, Jeannot E, Bioulac-Sage P, et al. Biallelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32:312-315
3. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007; 46:740-748 (Pubitemid 47436120)
4. Chen YW, Jeng YM, Yeh SH, Chen PJ. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 2002; 36:927-935
5. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43:515-524
6. Van der Borght S, Libbrecht L, Katoonizadeh A, et al. Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy. Histopathology 2007; 51:855-856 (Pubitemid 350179403)
7. Rebouissou S, Amessou M, Couchy G, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009; 457:200-204
8. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008; 48:808-818
9. Trillaud H, Bruel JM, Valette PJ, et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenterstudy in comparison to CT and MRI. World J Gastroenterol 2009; 15:3748-3756
10. Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR 2009; 193:55-60
11. Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR 2008; 190:58-66
12. Dietrich CF, Mertens JC, Braden B, Schuessler G, Ott M, Ignee A. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007; 45:1139-1145 (Pubitemid 46775775)
13. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled micro-bubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232:420-430 (Pubitemid 38971282)
14. Leen E, Ceccotti P, Kalogeropoulou C, Angerson WJ, Moug SJ, Horgan PG. Prospective multi-center trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR 2006; 186:1551-1559 (Pubitemid 46112517)
15. Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005; 78:704-707 (Pubitemid 41122683)
16. Nguyen AT, Bressenot A, Manole S, et al. Contrast-enhanced ultrasonography in patients with glycogen storage disease type Ia and adenomas. J Ultrasound Med 2009; 28:497-505
17. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007; 244:898-906 (Pubitemid 47292103)
18. Lewin M, Handra-Luca A, Arrive L, et al. Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology 2006; 241:433-440 (Pubitemid 44632889)
19. Wilson SR, Kim TK, Jang HJ, Burns PN. Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR 2007; 189:123; [web]W7-W12